Patients with lung cancer have higher breath temperature
the ONA take:
According to new research presented at the European Respiratory Society (ERS) International Congress in Munich, Germany, testing the temperature of breath may be an easy method to diagnose patients with lung cancer. In the study, researchers identified 82 patients to receive a breath temperature test after an x-ray examination suggested a diagnosis of lung cancer.
Researchers measured the patients' breath using an X-Halo device, a thermometer for breath. The X-Halo device confirmed lung cancer in 40 patients and rejected the diagnosis in 42 patients.
The researchers found that the patients with lung cancer had an increased breath temperature compared with those without lung cancer. In addition, the temperature rose with their lung cancer stage and the duration in which a patient had smoked. The researchers were also able to identify the cut-off temperature for which lung cancer could be proven accurately.
Researchers hope that they can refine this test to be used to diagnose patients with lung cancer by measuring their breath temperature. They suggest that the test would be simple, cheap, and noninvasive.
Testing the temperature of breath may be an easy method to diagnose patients with lung cancer.
The temperature of exhaled breath could be used to diagnose lung cancer, according to a new study. The research, presented at the European Respiratory Society (ERS) International Congress in Munich today (8 September 2013), suggests that testing the temperature of breath could be a simple and noninvasive method to either confirm or reject the presence of lung cancer.
Many research teams have been looking at the possibility of using breath tests for a number of cancers. This is the first study looking at breath temperature as a marker in lung cancer.
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
- Distress Management Tool Gets an Update, Patient Version
- PSA Screening Rates Level Off in United States
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|